Abbott’s Humira discount
The average sales price of Abbott's rheumatoid arthritis treatment Humira (adalimumab) is about 8% below its listed wholesale acquisition cost, Centers for Medicare & Medicaid Services data indicates. The Humira wholesale acquisition cost is $605.39 per 40 mg dose, according to Red Book. The average sales price of $555.91 per 40 mg is based on CMS' published second quarter Medicare Part B payment limit. Although the product is not reimbursed under Part B, average sales price data is reported for adalimumab because it is assigned a J-code, Abbott said...
You may also be interested in...
The firm licensed the TLR9 agonist SD-101 from Dynavax to test with its pressure-enabled drug delivery technology in liver and pancreatic settings where immuno-oncology has shown moderate efficacy or less.
Given inconsistent study results, robustness of the efficacy evidence is expected to be key focus of the 6 November meeting of the Peripheral and Central Nervous System Drugs Advisory Committee; review could put a December 2019 guidance on the ‘substantial evidence’ standard to the test and offer insight into the amount of flexibility the agency is willing to exercise for neurodegenerative diseases with high unmet need.
CRLs FDA submits in response to ANDAs increased most years since FY 2015, though FY 2020 total likely will be lower than two previous years. A 2019 CRL interrupted GSK's plans to market first mouth spray nicotine replacement therapy in US.